Brand Information

Updated On: 18-11-2024

Home

About Us

FAQs

Feedback

Disclaimer

Site Map

Home > Search > > XONE

XONE

Brand:
XONE

Manufacturer:
ALKEM

Manufacturer Details
ALKEM
Alkem laboratories Ltd. Dev Asish Bldg,Near Mautulya Centre Senapati Bapat Marg, Lower Parel Mumbai 400013

Compositions:
Ceftriaxone 125mg/250mg/500mg/1g injection,

Strength	Rate	Packing Style
125mg/250mg/500mg/1g inj	0.00	vial injection

List of Related Indications:

Pneumonia

List Of Drugs:

Ceftriaxone Na - Cephalosporins- @ Third generation- (FDC -List) (April 1988)

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Other Information

Patient Information

Pharmacology/ Pharmacokinetics

Interaction with Food

Pregnancy and lactation

Drug Interaction:

Post operative infections.

Drugs covered:

1st generation 2nd generation 3rd generation . Cephalexin Cefaclor Cefixime Cefadroxil Cefamandole Cefoperazone Cephadrine Cefotoxitin Cefotaxime Cephalothin Cefuroxime Ceftizoxime Cephapirin Cefonicid Ceftriaxone Cefazolin Cefmetazole Ceftazidime Cefotetan Ceftibuten Cefprozil Cefepime Cefpodoxime Loracarbef

Refer Cephalosporins

Disulfram like reaction with alcohol.

Indication:

U.S.FDA APPROVED DRUGS APPROVED FROM 01-01-08 TO 31-12-08

Drug name Indication Date of Approval

175. Ceftriaxone 18-08-08

+ Sulbactum injection

(Addl.indication)

For the treatment of acute bacterial otitis media,

skin & soft structure infections ,UTI, uncompliacted

gonorrhoea,pelvic inflammatory disease, bacterial

septicemia, bone and joint infections,intra abdominal

infections, meningitis,surgical prophylaxis

U.S.FDA APPROVED DRUGS DURING 2006

72. Ceftriaxone ( as sodium) 250mg + 05-07-2006

azobactam 31.25mg for injection (addl.stgth) Anti-biotic

U.S.FDA APPROVED DRUG DURING 2007

31. Ceftriaxone (as sodium)125mg/250mg + 01-03-2007

Sulbactum (as sodium ) 62.5mg/125mg

Injection (addl.stgth)

As approved

167. Ceftriaxone 2gm + 21-11-07

Tazobactum 250mg for injection As approved

A third generation drug

Approved by (DCI) Drug Controller GENERAL - India For Marketing

(Ref- IDMA Publication)

Name of Drug Indication Date of Approval

1. Ceftriaxone - Antibiotic April 1988

Sodium

2. Ceftriaxone sodium 01-03-2007

125mg/250mg + sulbactum as sodium

62.5mg/125mg for injection

Addl.Strgth

As approved

3. Ceftriaxone as sodium 250mg + 05-07-2006

Tazobactum 31.25mg for injection

Addl.stgth

Antibiotic

4. Cetriaxone + sulbactum injection 18-08-2008

Addl indication

For the treatment of acute bacterial otitis media, skin & soft

structutre infections, UTI, uncomplicated gonorrhoes, pelvic

inflammatory disease, bacterial septicemia, bone and joint

infections, intra abdominal infections, meningitis, surgical

prophylaxis

5. Cetriaxone 2gm + Tazobactum 21-11-2007

250mg for injection

As approved

6.Cetriaxome sodium equiv. to 21-09-2011

ceftriaxome sodium 1000mg/2000mg +

Sulbactum sodium equiv. to sulbactum

500mg/500mg

Addl Indication

For the treatment of urinary tract infections and lower respiratory

tract infections, variuos bacteria

FIXED DOSE COMBINATIONS APPROVED BY DCG(I)

FROM JANUARY 1961 TILL NOVEMBER 2014

Name of Drug Indication Date of Approval

1.Ceftriaxone sodium 500mg/1000mg + 12-08-2005

Sulbactum sodium 250mg/500mg for injection

For LRTI

2.Ceftriaxone sodium 250mg+ 07-05-2006

Tazobactum 31.25mg for injection

Addl.Stgth

Anti-bacterial

3.Ceftriaxone 0.125/0.25/0.5/1g + 21-07-2005

Tazobactum 15.625/31.25/62.5/125mg injection

For the treatment of patients with community acquired pneumonia

and lower respiratory tract infection

FIXED DOSE COMBINATIONS APPROVED BY DCG(I)

FROM JANUARY 1961 TILL NOVEMBER 2014

Name of Drug Indication Date of Approval

1.FDC of Ceftriaxone 500mg/1000mg + 21-07-2005

Tazobactum 62.5mg/125mg Injection

Antibacterial

Post operative infections.

Drugs covered:

Refer Cephalosporins

Adverse Reaction:

Anaphylactic reaction. Pseudomembranous colitis, Superinfection, Anaphylaxis, Diarrhoea, Local reactions, Blood dyscrasias, Rash.

Contra-Indications:

Hypersens to cephalosporins/penicillins

Special precautions: Infants less than 1 month, impaired renal function.

Dosages/ Overdosage Etc:

A third generation drug

Indications: post operative infections.

Dosage: Adults - Usual daily dose 1 to 2g once a day or equally divided dose twice in a day. Do not exceed total daily dose of 4g. For surgical prophylaxis- 1g dose half to 2 hours before surgery.

Children - Serious infections other than meningitis, 50 to 75mg/kg/day(not to exceed 2g) in divided dose every 12 hours. Meningitis - 100mg/kg/day(not to excceed 4g) in divided doses every 12 hours, with or without loading dose of 75mg/kg.

Storage: Protect from light, After reconstitution protection from normal light is not necessary.

Other Information:

For Availability/supplies

Contact -

1.Indian Drug Manufacturers Association (IDMA)

Phone- 022- 24944624/ 24974308

Fax- 022- 24950723

Email- idma@vsnl.com

Website: www.idma-assn.org

2.Bulk Drug Manufacturers Association (India)(BDMA)

Phone - 040-23703910/ 23706718

Fax- 040-23704804

Email- info@bdmai.org

Website: www.info@bdmai.org

Patient Information:

Refer cephalosporins

Pharmacology/ Pharmacokinetics:

Refer cephalosporins

Interaction with Food:

Refer cephalosporins

Pregnancy and lactation:

Refer cephalosporins

Search

Look In

Keyword

Mode

	Starts With		Contains

Quick Links

Home
About Us
FAQs
Site Map
Disclaimer

Free Mobile App

About Us

FAQs

Feedback

Disclaimer: Every effort has been made to ensure that the information provided in this Database is authentic and accurate. Commissions or omissions in the database, if any, are purely inadvertent and the site owner shall not accept any liability whatsoever for any adverse consequences of any nature arising to any individual or third party, as a result of usage of this information.